Literature DB >> 1307275

[Sensitivity in vitro of Plasmodium falciparum to chloroquine, pyronaridine, artesunate and piperaquine in south Yunnan].

H L Yang1, P F Yang, D Q Liu, R J Liu, Y Dong, C Y Zhang, D Q Cao, H He.   

Abstract

The sensitivity of P. falciparum to chloroquine, pyronaridine, artesunate and piperaquine (CQ, PD, AT, PQ) was assayed using in vitro microtechnique in south Yunnan in 1990. The resistance rates were 98.7% (75/76), 27.6% (16/58), 13.8% (9/65) and 97.7% (43/44) respectively, and ID50 were 125.0, 19.0, 4.7 and 243.3 nmol/L, respectively. The resistance rate against CQ showed no change as compared to the rates against CQ 5 and 9 years ago; but the ID50 was lower. CQ-resistant P. falciparum showed a marked cross-resistance to PQ, but not to PD and AT. AT-resistant P. falciparum exhibited cross-resistance to the above-mentioned three drugs. PD-resistant P. falciparum showed no cross resistance to AT, but showed cross resistance to CQ and PQ. In comparison with chloroquine-coated plates, the plates coated with pyronaridine, artesunate or piperaquine gave similar results as the former, which were shown by the rise in schizont inhibition rates along with the rise in drug concentration. It indicates that pyronaridine-, artesunate-, and piperaquine-coated plates can be used in the assay of sensitivity of P. falciparum to the three drugs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1307275

Source DB:  PubMed          Journal:  Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi        ISSN: 1000-7423


  8 in total

Review 1.  Piperaquine: a resurgent antimalarial drug.

Authors:  Timothy M E Davis; Te-Yu Hung; Ing-Kye Sim; Harin A Karunajeewa; Kenneth F Ilett
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  In vitro sensitivities of Plasmodium falciparum isolates from the China-Myanmar border to piperaquine and association with polymorphisms in candidate genes.

Authors:  Mingming Hao; Dandan Jia; Qing Li; Yongshu He; Lili Yuan; Shuhui Xu; Kexuan Chen; Jia Wu; Lijuan Shen; Lin Sun; Hongbin Zhao; Zhaoqing Yang; Liwang Cui
Journal:  Antimicrob Agents Chemother       Date:  2013-01-28       Impact factor: 5.191

3.  Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria.

Authors:  Te-Yu Hung; Timothy M E Davis; Kenneth F Ilett; Harin Karunajeewa; Sean Hewitt; Mey Bouth Denis; Chiv Lim; Doung Socheat
Journal:  Br J Clin Pharmacol       Date:  2004-03       Impact factor: 4.335

Review 4.  Artesunate. A review of its pharmacology and therapeutic efficacy in the treatment of malaria.

Authors:  L B Barradell; A Fitton
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

5.  In vitro activities of piperaquine and other 4-aminoquinolines against clinical isolates of Plasmodium falciparum in Cameroon.

Authors:  Leonardo K Basco; Pascal Ringwald
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

6.  Surveillance of antimalarial drug resistance in China in the 1980s-1990s.

Authors:  De-Quan Liu
Journal:  Infect Dis Poverty       Date:  2014-02-24       Impact factor: 4.520

7.  Evaluations of candidate markers of dihydroartemisinin-piperaquine resistance in Plasmodium falciparum isolates from the China-Myanmar, Thailand-Myanmar, and Thailand-Cambodia borders.

Authors:  Run Ye; Yilong Zhang; Dongmei Zhang
Journal:  Parasit Vectors       Date:  2022-04-12       Impact factor: 4.047

8.  Plasmodium berghei ANKA: selection of resistance to piperaquine and lumefantrine in a mouse model.

Authors:  D M Kiboi; B N Irungu; B Langat; S Wittlin; R Brun; J Chollet; O Abiodun; J K Nganga; V C S Nyambati; G M Rukunga; A Bell; A Nzila
Journal:  Exp Parasitol       Date:  2009-03-24       Impact factor: 2.011

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.